Condition: Leiomyoma (Uterine Fibroids) · Adenomyoma of Uterus · Uterine Bleeding · Sponsor: Erkan Gol
This prospective, single-center, randomized controlled trial aims to evaluate the effect of uterine manipulator use during total abdominal hysterectomy on postoperative female sexual function at 3 months, assessed by the Female Sexual Function Index (FSFI). Secondary outcomes include operative time, perioperative hemoglobin change, postoperative pain (VAS), hospital stay duration, and 30-day complications.
This description comes directly from the study's public registry record.
Erkan Göl, MD · +905398517917 · drerkangol@gmail.com
Always discuss trial participation with your own doctor first.
| Bakirkoy Dr. Sadi Konuk Training and Research Hospital | Istanbul, Istanbul, Turkey (Türkiye) | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07431788